Tradestie Institutional Equity Comparison Engine

CGON vs ZLAB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CGON Overall Edge

CGON Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CG Oncology, Inc. Common stock (CGON) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CGON trades at N/M Forward P/E with -4293.5% operating margin (-3.7% YoY revenue) versus ZLAB at N/M Forward P/E and -63.0% operating margin (-6.8% YoY). In options structure, CGON sits in CONSOLIDATION (85th %ile IV; Dealer Gamma Walls on Pro) against ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CGON N/M vs ZLAB N/M Fwd P/E
Growth & Margin Winner CGON
Op Margin -4293.5% vs -63.0% ยท YoY -3.7% vs -6.8%
Momentum & Technical Winner CGON
1Y +124.9% vs +9.7% ยท 52W Pos 84% vs 60%
Options & Structure Winner CGON
CONSOLIDATION (85th %ile IV) vs UNCLASSIFIED (58th %ile IV)
CGON NASDAQ
CG Oncology, Inc. Common stock
Biological Products, (No Disgnostic Substances)
$84.94
+14.16% 1D
Market Cap $6.3B
1M Return +41.91%
1Y Return +124.93%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 15.0 Fund 44.0 Flow 69.0 Mom 60.0
ZLAB NASDAQ
Zai Lab Limited American Depositary Shares
Pharmaceutical Preparations
$23.83
-3.13% 1D
Market Cap $3.0B
1M Return +2.76%
1Y Return +9.66%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 53.5

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CGON +124.93% ZLAB +9.66% Spread: +115.27 pp (CGON Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CGON TTM Op. Margin: -4293.5% ZLAB TTM Op. Margin: -63.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGON vs ZLAB. Trailing 12-month operating profitability (CGON -4293.5% vs ZLAB -63.0%) and valuation multiples (CGON N/M vs ZLAB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CGON (5) vs ZLAB (3)
Institutional Metric CGON ZLAB Criterion Row Winner
Market Capitalization Scale $6.3B $3.0B Larger Scale CGON
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -3.7% -6.8% Higher Growth CGON
Operating Margin (TTM) Profitability -4293.5% -63.0% Higher Margin ZLAB
Net Profit Margin Profitability 0.0% -44.9% Higher Margin CGON
Return on Equity (ROE) Capital Efficiency -28.3% -30.0% Higher ROE CGON
52-Week Range Position Momentum 84% ($37โ€“$94) 60% ($16โ€“$29) Stronger Trend CGON
Beta / 30D Volatility Risk Regime 0.77ฮฒ ยท 86% Vol 1.19ฮฒ ยท 78% Vol Lower Realized Risk ZLAB
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 47.4 / 100 (HOLD) Higher Composite ZLAB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CGON vs ZLAB Buy Guide
CGON CONSOLIDATION
62d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 85th %ile
IV Regime Extreme (>80th %ile)
Live CGON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ZLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CGON nor ZLAB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.